The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

Pancreas. 2021 Apr 1;50(4):469-493. doi: 10.1097/MPA.0000000000001792.

Abstract

This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Adrenal Gland Neoplasms / diagnosis
  • Adrenal Gland Neoplasms / therapy*
  • Humans
  • Medical Oncology / methods
  • Medical Oncology / standards
  • Neoplasm Metastasis
  • Neuroendocrine Tumors / diagnosis
  • Neuroendocrine Tumors / therapy*
  • North America
  • Paraganglioma / diagnosis
  • Paraganglioma / therapy*
  • Pheochromocytoma / diagnosis
  • Pheochromocytoma / therapy*
  • Societies, Medical